Tsyvunin, V., Shtrygol’, S., Havrylov, I., Shtrygol’, D. and Reus, A. 2022. SGLT-2 inhibitors as potential anticonvulsants: empagliflozin, but not dapagliflozin, renders a pronounced effect and potentiates the sodium valproate activity in pentylenetetrazole-induced seizures. ScienceRise: Pharmaceutical Science. 5 (39) (Oct. 2022), 83–90. DOI:https://doi.org/10.15587/2519-4852.2022.266065.